Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Some molecular-genetic markers, defining the pathogenesis of superficial and invasive bladder cancer].

Molekuliarnaia biologiia - 1 Jan 2000

Babaian A Iu, Kariakin O B, Teplov A A, Zaletaev D V, Nemtsova M V

Abstract excerpt

We have investigated deletions of 3p14, 9p21, 9q34, 17p13 (TP53) loci, activating FGFR3 mutations in exon 9 and aberrant methylation of RASSF1, RARbeta, P16, P14, CDH1 genes with the aim of the molecular pathogenesis pathways analysis of bladder cancer. FGFR3 activating mutations and 9p21 deletions were observed significantly more frequent in the group of non-invasive bladder cancer pTa than in minimally-invasive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosomes, Human, Pair 17
Share to Chromosomes, Human, Pair 3

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosomes, Human, Pair 9

Share to Neoplasm Invasiveness

Share to Neoplasm Metastasis

Share to Receptor, Fibroblast Growth Factor, Type 3

Share to Transcriptional Activation

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 22295571

Genes

FGFR3
CDH1
RASSF1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Some molecular-genetic markers, defining the pathogenesis of superficial and invasive bladder cancer].PMID 22295571Read ↗

[Recent advances in bladder urothelial carcinogenesis].Semantic proximity Read ↗

[THE SOMATIC MUTATIONS AND ABERRANT METHYLATION AS POTENTIAL GENETIC MARKERS OF URINARY BLADDER CANCER].Semantic proximity Read ↗

[Tracking the gatekeeper gene in the stages of carcinogenesis in the bladder].Semantic proximity Read ↗

Genetic alterations of chromosomes, p53 and p16 genes in low- and high-grade bladder cancerSemantic proximity Read ↗

Functional polymorphisms in the matrix metalloproteinase genes and their association with bladder cancer risk and recurrence: a mini-review.Semantic proximity Read ↗

[Correlation of FGFR3 mutations and chromosomal alterations in bladder cancer].Semantic proximity Read ↗

Role of MMP-3 and MMP-9 and their haplotypes in risk of bladder cancer in North Indian cohort.Semantic proximity Read ↗

Bladder cancer. I. Molecular and genetic basis of carcinogenesis.Semantic proximity Read ↗

Investigation of the relationship between MMP-1 (- 1607 1G/2G), MMP-3 (- 1171 5A/6A) gene variations and development of bladder cancer.Semantic proximity Read ↗

Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis.Semantic proximity Read ↗

TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.Semantic proximity Read ↗

Loss of heterozygosity of chromosome 13q33-34 region and molecular analysis of ING1 and p53 genes in bladder carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.